Proposed Best Practice Guidelines for Scientific Response Documents: A Consensus Statement from phactMI.

Area of Science:

• Pharmaceutical Information Dissemination
• Medical Communications
• Regulatory Compliance

Background:

• Medical Information Departments respond to unsolicited requests for off-label product information.
• Responses must be non-promotional, evidence-based, and scientifically balanced.
• Adherence to Food and Drug Administration (FDA) Draft Guidance is essential.

Purpose of the Study:

• To propose best practices for content generation of scientific response documents.
• To establish guidelines for creating scientifically accurate and unbiased responses.
• To ensure transparency and address potential concerns regarding commercial bias.

Main Methods:

• Adapting the structure and elements of systematic reviews.
• Defining key sections for scientific response documents.
• Identifying essential elements for each section to ensure quality and integrity.

Main Results:

• Recommended sections include: title, abstract, introduction, methods, results, discussion, and references.
• Elements within each section are tailored based on the specific request.
• Guidelines emphasize accuracy, truthfulness, and evidence-based content.

Conclusions:

• Implementing these best practices ensures scientific response documents are non-promotional and reliable.
• The proposed structure enhances transparency and scientific balance in communications.
• These guidelines support pharmaceutical manufacturers in meeting regulatory expectations.